Cargando…

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF

Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design...

Descripción completa

Detalles Bibliográficos
Autores principales: Turgay Çelik, Gayem İnayet, Sütçü, Havva Kömür, Akpak, Yaşam Kemal, Akar, Münire Erman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487334/
https://www.ncbi.nlm.nih.gov/pubmed/26161425
http://dx.doi.org/10.1155/2015/970163
_version_ 1782378989988347904
author Turgay Çelik, Gayem İnayet
Sütçü, Havva Kömür
Akpak, Yaşam Kemal
Akar, Münire Erman
author_facet Turgay Çelik, Gayem İnayet
Sütçü, Havva Kömür
Akpak, Yaşam Kemal
Akar, Münire Erman
author_sort Turgay Çelik, Gayem İnayet
collection PubMed
description Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design. A retrospective study in Akdeniz University, Faculty of Medicine, Department of Obstetrics and Gynecology, IVF Center, for 131 poor responders in the intracytoplasmic sperm injection-embryo transfer (ICSI-ET) program between January 2006 and November 2012. The groups were compared to the patients' characteristics, controlled ovarian stimulation (COH) results, and laboratory results. Results. Combination protocol was applied to 46 patients (group 1), and a single protocol was applied to 85 patients (group 2). In group 1, the duration of the treatment was longer and the dose of FSH was higher. The cycle cancellation rate was significantly higher in group 2 (26.1% versus 38.8%). A significant difference was not observed with respect to the number and quality of oocytes and embryos or to the number of embryos transferred. There were no statistically significant differences in the hCG positivity (9.5% versus 9.4%) or the clinical pregnancy rates (7.1% versus 10.6%). Conclusion. The combination protocol does not provide additional efficacy.
format Online
Article
Text
id pubmed-4487334
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44873342015-07-09 A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF Turgay Çelik, Gayem İnayet Sütçü, Havva Kömür Akpak, Yaşam Kemal Akar, Münire Erman Biomed Res Int Research Article Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design. A retrospective study in Akdeniz University, Faculty of Medicine, Department of Obstetrics and Gynecology, IVF Center, for 131 poor responders in the intracytoplasmic sperm injection-embryo transfer (ICSI-ET) program between January 2006 and November 2012. The groups were compared to the patients' characteristics, controlled ovarian stimulation (COH) results, and laboratory results. Results. Combination protocol was applied to 46 patients (group 1), and a single protocol was applied to 85 patients (group 2). In group 1, the duration of the treatment was longer and the dose of FSH was higher. The cycle cancellation rate was significantly higher in group 2 (26.1% versus 38.8%). A significant difference was not observed with respect to the number and quality of oocytes and embryos or to the number of embryos transferred. There were no statistically significant differences in the hCG positivity (9.5% versus 9.4%) or the clinical pregnancy rates (7.1% versus 10.6%). Conclusion. The combination protocol does not provide additional efficacy. Hindawi Publishing Corporation 2015 2015-06-16 /pmc/articles/PMC4487334/ /pubmed/26161425 http://dx.doi.org/10.1155/2015/970163 Text en Copyright © 2015 Gayem İnayet Turgay Çelik et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Turgay Çelik, Gayem İnayet
Sütçü, Havva Kömür
Akpak, Yaşam Kemal
Akar, Münire Erman
A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title_full A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title_fullStr A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title_full_unstemmed A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title_short A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
title_sort flexible multidose gnrh antagonist versus a microdose flare-up gnrh agonist combined with a flexible multidose gnrh antagonist protocol in poor responders to ivf
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487334/
https://www.ncbi.nlm.nih.gov/pubmed/26161425
http://dx.doi.org/10.1155/2015/970163
work_keys_str_mv AT turgaycelikgayeminayet aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT sutcuhavvakomur aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT akpakyasamkemal aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT akarmunireerman aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT turgaycelikgayeminayet flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT sutcuhavvakomur flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT akpakyasamkemal flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf
AT akarmunireerman flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf